Karriereverlauf von Yaping Shou
Ehemalige bekannte Positionen von Yaping Shou
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 23.04.2018 | 02.11.2020 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2011 | 01.06.2018 |
Ausbildung von Yaping Shou
| Drexel University College of Medicine | Doctorate Degree |
| Zhejiang University School of Medicine | Doctorate Degree |
| University of Pennsylvania | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Kanada | 2 |
| China | 2 |
Operativ
| Doctorate Degree | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Yaping Shou
- Erfahrung
